Improving the Quality of Care for Atrial Fibrillation by Promoting Patient-Centered Decision Making
NCT ID: NCT00829478
Last Updated: 2012-03-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
135 participants
INTERVENTIONAL
2008-10-31
2010-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of an Atrial Fibrillation Decision Support Tool (AFDST) on Thromboprophylaxis for Atrial Fibrillation
NCT02524977
"Info-AF" Information Preferences in Patients With Atrial Fibrillation/Flutter and the Association With Clinical Symptoms
NCT04299269
Feasibility Study to Improve AF Outcomes Using a Digital Application for CV Risk Reduction
NCT04050982
Shared Decision Making to Address Racial Disparities in Oral Anticoagulation in NVAF
NCT04956978
Decision Aids for Patients With Nonvalvular Chronic Atrial Fibrillation (DA4AFib)
NCT03744936
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The purpose of this study is to examine an intervention to improve the quality of decision-making for NVAF compared to usual care. The intervention has several components, including: a) educating the patient about why values and preferences are important to the decision-making process, b) providing an individualized assessment of the risks and benefits of each of the treatment options, c) exploring patients' values and preferences as they relate to the risks and benefits of each of the treatment options, d) preparing the patient to discuss his/her preferences with the physician.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Usual Care
Usual Care
Usual Care
2
Intervention
Decision Aid for Atrial Fibrillation
Single contact educational session
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Decision Aid for Atrial Fibrillation
Single contact educational session
Usual Care
Usual Care
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be scheduled to see primary Doctor at VA
* Diagnosis of atrial fibrillation
* English speaking
Exclusion Criteria
* Be on warfarin for a condition other than NVAF
* Have a contraindication to warfin
* Have a contraindication to ASA
* Life expectancy of less than 12 months
* Cognitive impairment
* Receiving anti-platelet agent other than aspirin
* Receiving care in a supervised resident clinic or from an attending physician who refuses participation in the study
* Bleed with identified source in the last 12 months
* Bleed with an unidentified source
* History of intracerebral hemorrhage
* Severe hearing impairment
* Severe visual impairment
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Donaghue Medical Research Foundation
OTHER
Yale University
OTHER
VA Connecticut Healthcare System
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Terri R Fried, M.D.
Role: PRINCIPAL_INVESTIGATOR
VA Connecticut HS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA Connecticut Healthcare System - West Haven Campus
West Haven, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Fried0011
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.